🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

📣 FOMO on #AHA24? Catch all the🫀🗞️highlights from the CardioNerds Conference Scholars by following CardioNerds & #AHA24👩‍⚕️👨‍⚕️ Amit Goyal MD MAS Daniel Ambinder, MD Naima Maqsood Gurleen Kaur, MD Ronaldo Correa Fabiano Chelsea Amo Tweneboah, MD Atefeh Ghorbanzadeh Maryam Barkhordarian Shikha Jha MD, CPPS, CPHQ🫀 Daniel K Amponsah, MD

Our career panel is phenomenal. We are discussing contract negotiations, finding your path, mentorship, and extra-curricular activities. #ACR24

Our staple rheumatology roundtables. A full house today! #ACR24

#FellowKaraokeFriday at #ACR24

I can’t begin to describe how much it filled me with joy to see Dr. Eloisa Bonfa receive the #ACR master designation. Seeing a great clinician and investigator from Brazil show up in that stage; and even more being from my home institution of USP, words can’t describe. 🇧🇷 1/

Superstar fellow Raisa Silva and incoming resident Manuel Carpio Tumba presenting #ACR24 poster on geographic, racial and ethnic representation in myositis clinical trials 🌟 Raisa Lomanto Silva, MD

Fangirling these two rockstars! A joy to work with shiri keret and Irada Choudhuri on ILD transplant-free survival predictors 🫁 Rohit Aggarwal

In our syst. review.. - Race fully reported in 57.9% RCTs - 42% of RCTs had >20% non-White participants; 21% if excluding RCTs conduted exclusively in Japan - 68.4% RCTs used sex/gender terms per SAGER guidelines Working with the best ⭐️ Didem Saygin, MD @SattuiSEMD Manuel Carpio Tumba

Abstract 333 showed that in a cohort of patients with IIM-ILD increased age, PH, FVC decline at 1 yr, SOB at 2 years were predictors for mortality and lung transplant ! #ACR24 Dr. John Cush

Flashback circa 2015, best slide at the Great Debate on MCTD! #ACR2024

#AHA24 Prior studies: ⬆️vol. physical act (PA) linked ⬆️CAC in suggesting early atherosclerosis Our findings: ⬆️Vol. PA was 🚫 linked w/ ⬆️CAC in asympt w/o CVD ELSA-Brasil cohort Longitudinal athlete-level data is lacking Thx my mentor Marcio S Bittencourt and all ELSA-Brasil

#HappyNewYear2025 Excited to receive the hard copy of our new #ultrasound in #rheumatology atlas! Order today link.springer.com/book/10.1007/9… Janeth Yinh MGH Rheumatology MSK Ultrasound Program Paul DeMarco #genekissinmd Minna Kohler, MD, RhMSUS #POCUS #meded #MEDX

Start spotlight, SO proud 🥹 ⭐️

Can an eFI be applied to a healthcare system, with incomplete data? Yes! Here we applied the VA Research VA-FI to the Mass General Brigham health record system. Congratulations Bharati Kochar Christine Seel Ritchie Rachelle Bernacki, MD, MS and team! agsjournals.onlinelibrary.wiley.com/doi/full/10.11… Andrew Clegg JAGS Brigham and Women’s Division of Aging

We have a great program lined up for this upcoming 2-hr webinar on #IBM dedicated to patients and providers, and it is cost free. Hope to see you all ! Myositis Support and Understanding (MSU) Cure IBM—Inclusion Body Myositis The Myositis Association anam hussain @aan

🆕 PJP Prophylaxis in #Rheumatology 🫁 Created with / Review by Cassandra Calabrese 🔹Discuss risk factors for PJP infection 🔹Risk Stratify: CD4 count <200 or ALC <500 = ⇡Risk 🔹Review Treatment options and when to stop PPx? #RheumX #RheumTwitter #PulmTwitter #PJP

Dr. Belen Arevalo & Dr. Zandra Walton present difficult #vasculitis cases from Mass General Brigham #MGB2025VasculitisPMR #meded #GCA #GPA #cranialnervepalsies #opticneuritis

RIVAWAR Trial: Rivaroxaban Is Comparable to Warfarin for Post-MI Left Ventricular Thrombus Written by Adam Alhassan MD, MPH! Summary, analysis and more #ACC25 coverage below! cardiologynownews.org/rivawar-trial-… C. Michael Gibson MD Cecilia Bahit

Idiopathic inflammatory #myositis -#ILD treatment #EULAR2025

New EULAR/ACR classification criteria for Antisynthetase Syndrome ✅ Anti-ARS antibodies & ILD are top drivers 🧪 ANA, SSA, MSA testing crucial to apply/exclude criteria 🧠 Score ≥5.5 + anti-ARS = definite ASyS ⏩ most weighted items = anti-ARS , ILD, myositis #EULAR2025